By modifying the peptide to bind strongly to albumin (an abundant blood protein) and resist enzymatic degradation, scientists created a GLP-1 agonist that required injection only once weekly
Both LIRA and SEMA have demonstrated nephroprotective effects in individuals with diabetes, suggesting that systolic blood pressure and HbA1c levelsrather than weightare the most influential mediators, although other factors also play a role (Fig
He was also counseled on what to expect with the new medication, including the possibility of experiencing gastrointestinal side effects with GLP-1 RA therapy and how to minimize them
Idiopathic Parkinsons disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients
Prime/MRx has been at the forefront of GLP-1 insights since we released our year-one research, and though we continue to see declines in persistence and adherence, we are committed to providing clients with actionable data and insights that can steer positive health outcomes for individuals, said David Lassen, PharmD, chief clinical officer at Prime/MRx